Clinical and radiographic evaluation of vital pulp therapy in open apex teeth with MTA and ZOE.
The purpose of this study was to report the success rate of using mineral trioxide aggregate (MTA) and zinc oxide eugenol (ZOE) as vital pulp therapy agents in immature permanent teeth with carious or traumatic pulp exposure. Subjects were children with permanent teeth requiring pulpotomy (apexogenesis) and without systemic diseases. Both ZOE and MTA treatments as pulpotomy agents showed clinical and radiographic success in immature permanent teeth. Although MTA was more successful, it is more expensive, and dentin bridges may develop over canal orifices, complicating future root canal therapy.
Dental Research Center, Faculty of Dentistry, Mashhad University of Medical Sciences, Iran. ghoddusij@mums.ac.ir
Jamileh
J
Ghoddusi
Fatemeh
F
Shahrami
Mahyareh
M
Alizadeh
Kamyar
K
Kianoush
Maryam
M
Forghani
D017607:Aluminum Compounds / Q000627:therapeutic use*; D017610:Calcium Compounds / Q000627:therapeutic use*; D002648:Child; D003785:Dental Pulp Capping / Q000379:methods*; D004338:Drug Combinations; D006801:Humans; D010087:Oxides / Q000627:therapeutic use*; D011446:Prospective Studies; D057872:Pulp Capping and Pulpectomy Agents / Q000627:therapeutic use*; D011671:Pulpitis / Q000000981:diagnostic imaging / Q000628:therapy*; D011672:Pulpotomy / Q000379:methods*; D011859:Radiography; D012189:Retrospective Studies; D017640:Silicates / Q000627:therapeutic use*; D019227:Tooth Apex / Q000000981:diagnostic imaging / Q000254:growth & development; D015035:Zinc Oxide-Eugenol Cement / Q000627:therapeutic use*
D017607:Aluminum Compounds; D017610:Calcium Compounds; D004338:Drug Combinations; D010087:Oxides; D057872:Pulp Capping and Pulpectomy Agents; D017640:Silicates; D015035:Zinc Oxide-Eugenol Cement; C086631:mineral trioxide aggregate